N Kreiger1, J Lacroix, M Sloan. 1. Division of Preventive Oncology, Research Unit, Cancer Care Ontario, Toronto, Ontario, Canada.
Abstract
PURPOSE: The aim of the study was to evaluate hormonal risk factors for carcinoma of the exocrine pancreas among postmenopausal women. METHODS: Mailed questionnaire data from 52 cases and 233 population-based controls in Ontario were used to assess parity, age at first birth, and other hormonal factors on pancreatic cancer risk. RESULTS: Reduced risk was seen with three or more pregnancies [adjusted odds ratio (OR) = 0.22, 95% confidence interval (CI) = 0.07-0.65] and use of oral contraceptives (adjusted OR = 0.36, 95% CI = 0.13-0.96), whereas no significant associations were found for age at menarche or menopause, or estrogen replacement therapy. Among parous women, later age at first full-term pregnancy significantly increased the risk of this cancer (adjusted OR = 4.05, 95% CI = 1.50-10.92 for ages 25-29 years, adjusted OR = 3.78, 95% CI = 1.02-14.06 for ages 30+ years). CONCLUSIONS: Our data support the hypothesis that pancreatic cancer is, at least in part, an estrogen-dependent disease; there is growing epidemiological evidence that aspects of reproductive history and hormonal exposure are associated with risk of this disease.
PURPOSE: The aim of the study was to evaluate hormonal risk factors for carcinoma of the exocrine pancreas among postmenopausal women. METHODS: Mailed questionnaire data from 52 cases and 233 population-based controls in Ontario were used to assess parity, age at first birth, and other hormonal factors on pancreatic cancer risk. RESULTS: Reduced risk was seen with three or more pregnancies [adjusted odds ratio (OR) = 0.22, 95% confidence interval (CI) = 0.07-0.65] and use of oral contraceptives (adjusted OR = 0.36, 95% CI = 0.13-0.96), whereas no significant associations were found for age at menarche or menopause, or estrogen replacement therapy. Among parous women, later age at first full-term pregnancy significantly increased the risk of this cancer (adjusted OR = 4.05, 95% CI = 1.50-10.92 for ages 25-29 years, adjusted OR = 3.78, 95% CI = 1.02-14.06 for ages 30+ years). CONCLUSIONS: Our data support the hypothesis that pancreatic cancer is, at least in part, an estrogen-dependent disease; there is growing epidemiological evidence that aspects of reproductive history and hormonal exposure are associated with risk of this disease.
Authors: Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik Journal: World J Gastroenterol Date: 2011-06-28 Impact factor: 5.742
Authors: Eunjung Lee; Pamela L Horn-Ross; Rudolph P Rull; Susan L Neuhausen; Hoda Anton-Culver; Giske Ursin; Katherine D Henderson; Leslie Bernstein Journal: Am J Epidemiol Date: 2013-09-05 Impact factor: 4.897
Authors: Jeanine M Genkinger; Ruifeng Li; Donna Spiegelman; Kristin E Anderson; Demetrius Albanes; Leif Bergkvist; Leslie Bernstein; Amanda Black; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Pamela L Horn-Ross; Eric J Jacobs; Anita Koushik; Satu Männistö; James R Marshall; Anthony B Miller; Alpa V Patel; Kim Robien; Thomas E Rohan; Catherine Schairer; Rachael Stolzenberg-Solomon; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-12-22 Impact factor: 4.254
Authors: Yuqing Zhang; Patricia F Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg Journal: Cancer Causes Control Date: 2009-11-26 Impact factor: 2.506
Authors: Karin A Rosenblatt; Dao L Gao; Roberta M Ray; Zakia C Nelson; Karen J Wernli; Wenjin Li; David B Thomas Journal: Cancer Causes Control Date: 2008-08-15 Impact factor: 2.506
Authors: Richard J Stevens; Andrew W Roddam; Jane Green; Kirstin Pirie; Diana Bull; Gillian K Reeves; Valerie Beral Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-05 Impact factor: 4.254